Tetrabenazine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1816 publications

Severe neurotoxicity from accidental tetrabenazine ingestion in a child, with laboratory confirmation.

Severe neurotoxicity from accidental tetrabenazine ingestion in a child, with laboratory confirmation.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: April 09, 2026

The diagnostic value of 18F-AV-133 VMAT2 hybrid PET-MRI for cognitive impairment in Parkinson's disease

The diagnostic value of 18F-AV-133 VMAT2 hybrid PET-MRI for cognitive impairment in Parkinson's disease

Journal: Zhonghua yi xue za zhi

Published: January 26, 2026

Small Gold Nanoparticles Alleviate Huntington's Disease via Modulating p38α Mitogen-Activated Protein Kinase and Pyruvate Dehydrogenase Kinase 1.

Small Gold Nanoparticles Alleviate Huntington's Disease via Modulating p38α Mitogen-Activated Protein Kinase and Pyruvate Dehydrogenase Kinase 1.

Journal: ACS nano

Published: December 22, 2025

Physician experience and perceptions of tetrabenazine for the treatment of tardive dyskinesia and Huntington's chorea: a survey of neurologists and psychiatrists.

Physician experience and perceptions of tetrabenazine for the treatment of tardive dyskinesia and Huntington's chorea: a survey of neurologists and psychiatrists.

Journal: Expert review of neurotherapeutics

Published: December 19, 2025

Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Journal: Clinical pharmacology in drug development

Published: December 10, 2025

Consensus Molecules Associated with Parkinson's Disease.

Consensus Molecules Associated with Parkinson's Disease.

Journal: Neurology international

Published: November 20, 2025

Pharmacological evaluation of Orai-1 inhibitor in 3-nitropropionic acid-induced Huntington disease.

Pharmacological evaluation of Orai-1 inhibitor in 3-nitropropionic acid-induced Huntington disease.

Journal: The Journal of pharmacy and pharmacology

Published: November 15, 2025

When Stroke Mimics a Subthalamic Lesion: An Unusual Presentation of Hemichorea-Hemiballismus.

When Stroke Mimics a Subthalamic Lesion: An Unusual Presentation of Hemichorea-Hemiballismus.

Journal: Cureus

Published: October 29, 2025

VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review.

VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review.

Journal: CNS spectrums

Published: October 22, 2025

Optimization of Ionic Liquid Based NLC for Nose-To-Brain Delivery of Tetrabenazine Hydrochloride.

Optimization of Ionic Liquid Based NLC for Nose-To-Brain Delivery of Tetrabenazine Hydrochloride.

Journal: AAPS PharmSciTech

Published: October 18, 2025

Hyperglycaemia Presenting With Hemichorea: A Rare Case of Diabetic Striatopathy With Ketosis.

Hyperglycaemia Presenting With Hemichorea: A Rare Case of Diabetic Striatopathy With Ketosis.

Journal: Cureus

Published: October 18, 2025

Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis.

Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: October 11, 2025

Showing 1-12 of 1,816

Last Updated: 04/28/2026